Science in the State of the Union

President Barack Obama gave a nod to research in this week’s address. But was it enough for science advocates?

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, CHUCK KENNEDYIn a wide ranging State of the Union speech on Tuesday night (January 28), which ran the gamut from immigration reform and job creation to health care and national security, President Barack Obama mentioned the importance of basic research, though he did not unveil any new science policies on the horizon. Among the scientific topics broached by the President: climate change (“Climate change is a fact. And when our children’s children look us in the eye and ask if we did all we could to leave them a safer, more stable world, with new sources of energy, I want us to be able to say yes, we did.”), science funding (“Federally funded research helped lead to the ideas and inventions behind Google and smartphones. And that’s why Congress should undo the damage done by last year’s cuts to basic research so we can unleash the next great American discovery.”), and patent reform (“There are entire industries to be built based on vaccines that stay ahead of drug-resistant bacteria, or paper-thin material that’s stronger than steel. And let’s pass a patent reform bill that allows our businesses to stay focused on innovation, not costly and needless litigation.”)

Obama has gotten somewhat mixed reviews from science advocates on his treatment of some topics in the annual speech. “Scientific and technological advances keep our nation internationally competitive and spur the innovation ecosystem fueling economic growth, but we have lost ground in recent years, due to research appropriations that have not kept pace with rising costs or international competition,” said Margaret Offerman, president of the Federation of American Societies for Experimental Biology (FASEB), in a statement. “We are thus grateful to President Obama for making research and innovation a national priority.” In a statement, the American Society for Biochemistry and Molecular Biology (ASBMB) also praised Obama for “reaffirming his administration’s commitment to support the nation’s scientific research and development capabilities.” But ASBMB also called on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies